MRI and blood test to track brain tumor changes
Part of Cancer clinical trials.
This study tests whether a special MRI scan and a blood test can help predict how a specific type of brain tumor (malignant glioma) changes over time. It is for people starting standard radiation and chemotherapy on a special machine that combines MRI and radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 21.
- You have been newly diagnosed with a grade 4 malignant glioma (a type of brain tumor).
- You are able to do most daily activities on your own (a score of 60 or above on the Karnofsky scale).
- You have not had any other cancer (except minor skin cancer) in the last 5 years.
- You do not have an iron metabolism disorder (like hemochromatosis) or anything that would prevent an MRI (like certain metal implants or severe claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses repeated MRI scans with a contrast dye to help doctors tailor (adapt) your radiation treatment over time for a high-grade glioma. It may help improve how accurately radiation targets the tumor as it changes.
This study tests a new MRI scanning method to see if it can better monitor glioblastoma after standard treatment. It may help doctors detect tumor changes earlier and guide future care.
This study tests how best to measure and track glioblastoma treatment while using MRI (a body scanner) to guide radiation. It may help improve how doctors assess the radiation response during therapy.
This study is testing whether special MRI scans and blood tests can help tell the difference between true tumor growth (progression) and a treatment-related reaction called 'pseudoprogression' in people with glioblastoma. The goal is to make treatment decisions more accurate.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
This trial tests a special MRI technique to guide surgeons in removing more of the brain tumor during surgery. The goal is to help people with glioblastoma live longer.
Hear when a new Malignant Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.